NASDAQ:ALVO - Nasdaq - LU2458332611 - Common Stock - Currency: USD
Taking everything into account, ALVO scores 4 out of 10 in our fundamental rating. ALVO was compared to 551 industry peers in the Biotechnology industry. There are concerns on the financial health of ALVO while its profitability can be described as average. ALVO is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.75% | ||
ROE | N/A | ||
ROIC | 10.37% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 21.88% | ||
PM (TTM) | 16.42% | ||
GM | 60.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | N/A | ||
Altman-Z | -0.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.73 | ||
Quick Ratio | 1.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 17.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 23.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
8.79
-0.27 (-2.98%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | 17.77 | ||
P/S | 4.54 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | N/A | ||
P/tB | N/A | ||
EV/EBITDA | 23.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.75% | ||
ROE | N/A | ||
ROCE | 13.13% | ||
ROIC | 10.37% | ||
ROICexc | 10.8% | ||
ROICexgc | 11.19% | ||
OM | 21.88% | ||
PM (TTM) | 16.42% | ||
GM | 60.74% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | N/A | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 7.35 | ||
Cap/Depr | 234.04% | ||
Cap/Sales | 12.89% | ||
Interest Coverage | 2.32 | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.73 | ||
Quick Ratio | 1.19 | ||
Altman-Z | -0.56 |